慢性完全閉塞 皮膚経冠動脈介入:2026年更新
Semih Ceylan1, Deniz Mutlu2, Eleni Kladou3
1Bahcesehir University School of Medicine, Istanbul, Turkey.
The Journal of invasive cardiology
|February 19, 2026
まとめ
慢性完全閉塞 (CTO PCI) の皮膚経冠動脈介入は,症状と放射線被曝が軽減され,専門センターでは90%以上の成功率を示しています. 新しい技術とAIによって,成果が向上しています.
科学分野:
- 心臓病学 心臓病学
- 介入性心臓病学 介入性心臓病学
- 医療技術 医療技術について
背景:
- 慢性完全閉塞 (CTO) 経皮冠動脈干渉 (PCI) は,進化する戦略を持つ複雑な手順です.
- 最近のイメージング,機器,技術の進歩により,CTO PCIの成果が向上しています.
- 最新の進展を理解することは,介入性心臓科医にとって極めて重要です.
研究 の 目的:
- CTO PCIに関する最新の出版文献をレビューし,要約する.
- 最近の進歩を手続き上の結果,技術,および合併症によって分類する.
- CTO PCIの将来を形作る進行中の研究を強調する.
主な方法:
- 2023年9月から2025年4月までのCTO PCIに関する出版文献の体系的なレビュー.
- 処置の成功,新技術,合併症,新興の研究に基づく発見の分類.
- マルチセンターデータと進行中のランダム化試験の分析.
主要な成果:
- 技術的な成功率は,専門家センターで報告された90%を超えています.
- CTO PCI後のアンギナと呼吸不全の長期的な減少.
- 機器のアップグレードとオペレーターの認識による放射線被曝の減少.
- 冠動脈CTガイド,血管内超音波,水力ダイナミックリカナライゼーション,逆行アプローチ,AIツールなどの技術で成功と安全性が向上しました.
結論:
- CTO PCIは急速に進歩しており,高い成功率と改善された患者の結果を提供しています.
- 技術革新と精巧なテクニックは,CTO PCIの進歩の主要な原動力です.
- 進行中の研究と大規模なレジストリにより,CTOのPCI戦略と実践パターンがさらに精錬されるでしょう.
関連する概念動画
Peripheral Artery Disease III: Interprofessional Care
388
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
388
Coronary Artery Disease V: Interprofessional Care
320
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
320
Acute Coronary Syndrome IV: Interprofessional Care
315
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
315
Acute Coronary Syndrome III: Diagnostic Studies
312
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
312
Peripheral Artery Disease V: Postoperative Nursing Management
431
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
431
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
487
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
487


